Semaglutide is an active ingredient in Wegovy and Ozempic. Those who can’t get their hands on the brand name or afford it are turning to compounded semaglutide.
SACRAMENTO, Calif. —
In 2021, the FDA approved Wegovy, a medication specifically for chronic weight loss management in adults. It’s the first drug of its kind since 2014 and Wegovy maker Novo Nordisk says “at least 25,000 new U.S. patients starts on Wegovy weekly,” and the number is growing.
Semaglutide is an active ingredient in Wegovy and a second drug made by Novo Norodisk named Ozempic. Semaglutide mimics a type of hormone our gut produces when we eat a meal. It sends signals to different organs when we eat. It tells us when we are full and suppresses appetites. It’s also known to slow down gastric emptying, so you feel fuller longer.
Wegovy uses a prefilled pen to dose injections weekly. Without insurance, Wegovy costs about $1,350 for a month supply, totaling to more than …
![QuicksortRx Named Second Fastest-Growing Company in South Carolina [Video]](https://marketingprohub.com/wp-content/uploads/2024/10/mp_696475_0_hqdefaultjpg.jpg)
![Mark Zuckerberg Predicts Smart Glasses Will Dominate the 2030s [Video]](https://marketingprohub.com/wp-content/uploads/2024/10/mp_692065_0_Untitleddesign61png.png)
![Vodafone Highlights the Power of Connectivity in New Brand Campaign by Grey London [Video]](https://marketingprohub.com/wp-content/uploads/2024/10/mp_695885_1_EffieMPU300x250gif.gif)
